Dr. Hawkins will work alongside the center’s director, Raymond DuBois, MD, PhD, to further establish it as a comprehensive cancer center. Right now, the MUSC Hollings Cancer Center is the only National Cancer Institute-designated cancer center in the state.
Achieving comprehensive cancer center status requires transdisciplinary research and an in-depth focus on population science, research and cancer prevention. Dr. DuBois hopes to achieve the level-up designation by 2028.
Joining the cancer center to co-lead alongside its director, Dr. Hawkins will also prioritize expanding the translational research program to more seamlessly integrate lab research into clinical treatment settings, according to the release.
